Sentences with phrase «gynecologic cancers»

Endometrial cancer is the most common type of gynecologic cancer in developed countries.

An oral cancer drug improves outcomes while minimizing side effects in women with gynecologic cancers who carry a BRCA mutation and whose disease is not responding to other therapies, suggests preliminary research.

More than one - third of counties in the Unites States are located more than 50 miles from the nearest gynecologic oncologist, making access to specialty care for ovarian and other gynecologic cancers difficult for nearly 15 million women.

Ovarian cancer is the leading cause of death from gynecologic cancer in the United States.

Shalowitz and colleagues suggest future studies should focus on defining areas with poor clinical outcomes attributed to geographic factors, and creating a comprehensive national, geographically - linked database on the utilization of gynecologic cancer care and clinical outcomes.

Our clinical trials for gynecologic cancers offer patients access to cutting - edge therapies that may not be available anywhere else.

Gynecologic Cancer InterGroup (GCIG) consensus review for vulvovaginal melanomas.

The five main types of gynecologic cancers include: uterine, cervical, vaginal, vulvar, and ovarian.

The registry tracks the medical history of patients with specific gynecologic cancers who may have been exposed to diethylstilbestrol (DES) or other synthetic hormones while still in their mother's womb.

February 14, 2011 Few women seek help for sexual issues after cancer treatment, but many want it Many women who survive breast and gynecologic cancers want medical help for their sexual issues, but most do not get it.

Our specialists are experienced in detecting and treating gynecologic cancers with the latest medical and surgical treatments.

Cervical cancer is the easiest gynecologic cancer to prevent with regular screening test and follow - up.

«Targeted Cancer Therapy May Treat Resistant Gynecologic Cancers.»

Gynecologic cancer cells that have a BRCA mutation appear to be sensitive to veliparib, which targets an enzyme called PARP (poly ADP - ribose polymerase), according to a Phase II study being presented at the Society of Gynecologic Oncology (SGO) Annual Meeting on Women's Cancer in Tampa, Fla., March 22 - 25.

«Based on our estimates, it's likely that more than 7,000 women with gynecologic cancers per year experience distance - related barriers to accessing appropriate care from a specialist.

«This is the first national study to identify specific regions of the United States where residents may be at an increased risk for poor clinical outcomes — including misdiagnoses and late detection — as a result of limited access to specialized gynecologic cancer care,» says David Shalowitz, MD, a fellow in the division of Gynecologic Oncology at the Perelman School of Medicine at the University of Pennsylvania, and lead author on the study.

The drug, birinapant, sensitizes the CA125 - negative cells to the chemotherapy by restoring apoptosis, or programmed cell death, said Dr. Sanaz Memarzadeh, a senior author of the study and a UCLA gynecologic cancer surgeon.

Cervical cancer is the third most common gynecologic cancer in the United States, and takes the life of one of every three women diagnosed with it.

«Unfortunately, due to the lack of screening mechanisms for many gynecologic cancers, they are often diagnosed in an advanced stage, thus leading to poor treatment response with standard therapies in many cases.

«Poor responding gynecologic cancers get boost from genomic profiling.»

Research from Rutgers Cancer Institute of New Jersey examining gynecologic cancers that poorly respond to therapy shows genomic profiling can help identify alternate and targeted treatments.

Gynecologic cancer typically originates from the female reproductive organs, and include endometrial and ovarian cancer, among others.

Ovarian cancer remains the most lethal gynecologic cancer in the United States.

With only a few days left of Gynecologic Cancer Awareness month, we can't think of a more appropriate time to share some of what we know about these cancers that originate in the female reproductive organs — and the CRI scientists who are doing their part to change the course of the fight against them.

Her professional and research interests include familial gynecologic cancers; cancer susceptibility in rare genetic syndromes; and psychosocial counseling in cancer - prone families.

Differences in C - type lectin receptors and their adaptor molecules in the peritoneal fluid of patients with endometriosis and gynecologic cancers Seung Geun Yeo, Yong Sung Won, Sang Hoon Kim, Dong Choon Park International Journal of Medical Sciences 2018; 15:411 - 416

Here, Kebria, gives us a preview of his panel and shares information about advances in combating gynecologic cancers:

Every year, 10,000 U.S. women are diagnosed with cervical cancer, and 3,600 die from the disease, according to Debbie Saslow, PhD, director of breast and gynecologic cancer at the American Cancer Society in Atlanta.

In fact, its the most fatal gynecologic cancer.

WEDNESDAY, March 21, 2018 (HealthDay News)-- Pap tests have helped drive down rates of cervical cancer, and a new study suggests they also could be used to detect other gynecologic cancers early.

All proceeds are donated to gynecologic cancer research.

Gynecologic Cancer Care University of Chicago Obstetrics and Gynecology Specialty Services Pavilion A 1890 Silver Cross Blvd., Suite 475 New Lenox, IL 60451 773-702-6118 Directions

Many women who survive breast and gynecologic cancers want medical help for their sexual issues, but most do not get it.

My primary research focus has been in the use of individualized approach in the management of gynecologic cancer, extremity soft tissue sarcoma through molecular markers and precision radiotherapy.

As part of an ongoing clinical trial at Rutgers Cancer Institute exploring rare and poor prognosis cancers, investigators sought to identify genomic alterations in 69 patients with gynecologic cancers that were not responding to standard care.

GYN Cancer Support Group - For patients who are diagnosed with a gynecologic cancer.

Institut Curie combines a research center and hospital focusing on the diagnosis and treatment of cancer, and specializing in breast and gynecologic cancers, and pediatric tumors.

«Nearly 10 percent of women live too far from access to gynecologic cancer care.»

Ovarian cancer accounts for 5 percent of cancer deaths among women, and causes more deaths than any other gynecologic cancer.

For women with ovarian cancer, a particularly deadly form of gynecologic cancer, even improvements in treatment outcomes have been elusive.

The four - year study involved 461 patients at 24 medical oncology clinics at Princess Margaret Cancer Centre, University Health Network (UHN) with advanced lung, gastrointestinal, genitourinary, breast and gynecologic cancers.

According to the Centers for Disease Control and Prevention, 71,500 women are diagnosed with a gynecologic cancer each year in the United States, with 26,500 deaths from one of these diseases.

The study, «Prognostic effects of peripheral and tumor - infiltrating T - cell repertoire diversity in ovarian cancer,» is ASCO 2016 abstract no. 5546 and will be exhibited on poster board no. 369 during the Gynecologic Cancer poster session Monday, June 6, from 1 p.m. to 4:30 p.m. CDT in McCormick Place, Hall A.

To learn more about current immunotherapy treatment options for women with gynecologic cancers, and how close we are to making these treatments available to more patients, watch Dr. Odunsi's webinar from June 4, 2013.

In my laboratory at NYU Langone, I focus on precision medicine, rare tumors, and early detection and prevention of gynecologic cancers.